APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

Completed · Phase 3 · Has a placebo group

Conditions studied: Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific

In brief

This randomized phase III trial is studying APF530 and dexamethasone to see how well they work compared with palonosetron and dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for cancer.

Key facts

Study ID
NCT00343460
Run by
Heron Therapeutics
People needed
1428
Starts
2006-06-01
Expected to finish
2009-02-01
Last updated by the study team
2026-03-02

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.